FMR CORP 13D and 13G filings for Zentalis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-06 11:44 am Sale |
2024-11-29 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
FMR CORP | 175,863 0.200% |
-4,899,974 (-96.54%) |
Filing |
| 2024-10-07 11:37 am Sale |
2024-10-04 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
FMR CORP | 5,075,837 7.138% |
-5,261,134 (-50.90%) |
Filing |
| 2024-02-09 10:05 am Purchase |
2024-02-08 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
FMR CORP | 10,336,971 14.607% |
2,427,795 (+30.70%) |
Filing |
| 2023-02-09 12:46 pm Purchase |
2023-02-09 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
FMR CORP | 7,909,176 13.858% |
1,113,345 (+16.38%) |
Filing |
| 2022-02-09 10:04 am Purchase |
2022-02-08 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
FMR CORP | 6,795,831 14.999% |
703,753 (+11.55%) |
Filing |
| 2021-02-08 10:35 am Purchase |
2021-02-05 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
FMR CORP | 6,092,078 14.999% |
1,085,906 (+21.69%) |
Filing |
| 2020-11-10 10:27 am Purchase |
2020-11-09 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
FMR CORP | 5,006,172 12.323% |
5,006,172 (New Position) |
Filing |